A Phase IIb dose range finding study of GRC-27864 in patients with moderate osteoarthritic pain.
Phase of Trial: Phase II
Latest Information Update: 18 Jan 2018
At a glance
- Drugs GRC 27864 (Primary)
- Indications Pain
- Focus Adverse reactions
- Sponsors Glenmark Pharmaceuticals Ltd
- 18 Jan 2018 New trial record
- 15 Jan 2018 According to a Glenmark Pharmaceuticals media release, the Directorate General of Health Services, Central Drugs Standard Control Organization (CDSCO), Government of India has granted permission to conduct this trial.